Cargando...
Denosumab and Teriparatide Transitions in Postmenopausal Osteoporosis (The DATA-Switch Study): a Randomised Controlled Trial
BACKGROUND: Unlike most chronic diseases, approved osteoporosis treatments are generally limited to a single drug at a fixed dose and frequency. Nonetheless, no approved therapy is able to restore skeletal integrity in most osteoporotic patients and the long-term use of most osteoporosis drugs remai...
Guardado en:
| Publicado en: | Lancet |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4620731/ https://ncbi.nlm.nih.gov/pubmed/26144908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(15)61120-5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|